-
There are a number of abnormalities apparent in the 12-lead ECG image. First, the rhythm is not sinus, as upright P waves are not seen in lead II.
-
The FDA has approved an oral, once-daily drug for the treatment of chronic hepatitis B. Telbivudine is the β-L enantiomer of thymidine with potent antiviral activity against hepatitis B virus.
-
A review of ambulatory medical malpractice cases of missed and delayed diagnoses reveals that they result from a witches' brew of multiple breakdowns, cognitive errors, and dysfunctional systems.
-
Annual CT scanning of at risk people can detect early (Stage 1) lung cancers and perhaps reduce the mortality rate of lung cancer in this group.
-
-
In response to several high-profile drug misadventures including the rofecoxib (Vioxx®) withdrawal from the market, the FDA's Center for Drug Evaluation and Research (CDER) asked the Institute of Medicine (IOM) to assess the drug safety system in the United States.
-
HIV clinicians and researchers still are learning how HIV evolves through mutations and development of resistance. If patterns of increasing resistance emerge then this has serious implications for HIV treatment and prevention.
-
Three years of experience using the rapid HIV test have shown New Jersey public health officials that using the rapid test is preferred by clients, and the results are reliable, a recent study shows.
-
Since 1995, the outlook for patients with HIV infection has improved significantly with the advent of triple-drug-potent antiretroviral (ARV) therapy regimens.
-
The Food and Drug Administration (FDA) is warning healthcare professionals regarding the significantly increased risk for serious and life-threatening cardiovascular (CV) complications associated with normalization of hemoglobin levels in patients receiving erythropoiesis-stimulating agents (ESAs).